Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Minimed Group Inc (MMED)

Minimed Group Inc (MMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,807,825
  • Shares Outstanding, K 280,813
  • Annual Sales, $ 2,715 M
  • Annual Income, $ -250,000 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales 1.32
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Services

Options Overview Details

View History
  • Implied Volatility 94.44% (-9.01%)
  • Historical Volatility N/A
  • IV Percentile 20%
  • IV Rank 2.39%
  • IV High 231.88% on 03/19/26
  • IV Low 91.09% on 04/06/26
  • Expected Move (DTE 8) 2.98 (22.04%)
  • Put/Call Vol Ratio 4.67
  • Today's Volume 17
  • Volume Avg (30-Day) 85
  • Put/Call OI Ratio 8.39
  • Today's Open Interest 1,268
  • Open Int (30-Day) 517
  • Expected Range 10.53 to 16.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.80 +5.47%
on 04/07/26
18.68 -27.75%
on 03/10/26
-4.50 (-25.00%)
since 03/09/26

Most Recent Stories

More News
MiniMed Announces FDA Clearance of MiniMed Flex™, the Company's Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design

MiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive algorithm to automatically adjust and autocorrect insulin delivery...

MMED : 13.65 (+0.66%)
MiniMed announces closing of Initial Public Offering

NORTHRIDGE, Calif. , March 9, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED) today announced the closing of its previously announced initial public offering (IPO) of 28,000,000...

MMED : 13.65 (+0.66%)
MiniMed to begin trading on Nasdaq Global Select Market

GALWAY, Ireland , March 6, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that MiniMed Group, Inc. (Nasdaq: MMED) will begin trading today on...

MMED : 13.65 (+0.66%)
MDT : 88.19 (-0.52%)
MiniMed announces launch of IPO roadshow

GALWAY, Ireland , Feb. 24, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced that it has launched a roadshow for the initial...

MMED : 13.65 (+0.66%)
MDT : 88.19 (-0.52%)
This May be One of the Biggest Catalysts for Psychedelic Stocks in 2024

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression....

NUMIF : 0.0106 (+12.77%)
CMPS : 5.61 (-1.92%)
ATAI : 3.69 (-1.86%)
NUMI.TO : 0.0500 (+42.86%)
MMED : 13.65 (+0.66%)
MNMD : 15.02 (+1.01%)
SEEL : 0.3900 (-27.79%)
Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change...

NUMIF : 0.0106 (+12.77%)
CMPS : 5.61 (-1.92%)
ATAI : 3.69 (-1.86%)
NUMI.TO : 0.0500 (+42.86%)
NUMI : 25.12 (+0.26%)
MMED : 13.65 (+0.66%)
MNMD : 15.02 (+1.01%)
SEEL : 0.3900 (-27.79%)
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition

EQNX::TICKER_START (NYSE:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(NASDAQ:ATAI) EQNX::TICKER_END

CMPS : 5.61 (-1.92%)
CYBN.NE : 11.5800 (+4.23%)
ATAI : 3.69 (-1.86%)
MMED.NE : 14.9000 (+9.48%)
MMED : 13.65 (+0.66%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
SEEL : 0.3900 (-27.79%)
Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031

EQNX::TICKER_START (NYSE:CYBN),NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(OTCQX:NUMIF) EQNX::TICKER_END

NUMIF : 0.0106 (+12.77%)
CMPS : 5.61 (-1.92%)
CYBN.NE : 11.5800 (+4.23%)
MMED.NE : 14.9000 (+9.48%)
NUMI.TO : 0.0500 (+42.86%)
MMED : 13.65 (+0.66%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
SEEL : 0.3900 (-27.79%)
Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031

/PRNewswire/ -- Psychedelic and hallucinogenic medicines market have been growing consistently over the past several years and are expected to continue to rise...

NUMIF : 0.0106 (+12.77%)
CMPS : 5.61 (-1.92%)
NUMI.TO : 0.0500 (+42.86%)
MMED : 13.65 (+0.66%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
SEEL : 0.3900 (-27.79%)
MindMed Reports First Quarter 2023 Financial Results and Business Highlights

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders,...

MMED.NE : 14.9000 (+9.48%)
MMED : 13.65 (+0.66%)
MNMD : 15.02 (+1.01%)

Business Summary

Midas Medici Group Holdings, Inc. was incorporated in the State of Delaware on October 30, 2006 under the name Mondo Acquisition I, Inc. The Company was formed as a vehicle to pursue a business combination through the acquisition of, or merger with, an operating business. On May 15, 2009, it, Mondo Management...

See More

Key Turning Points

3rd Resistance Point 14.56
2nd Resistance Point 14.15
1st Resistance Point 13.86
Last Price 13.65
1st Support Level 13.16
2nd Support Level 12.75
3rd Support Level 12.46

See More

52-Week High 20.48
Fibonacci 61.8% 17.55
Fibonacci 50% 16.64
Fibonacci 38.2% 15.73
Last Price 13.65
52-Week Low 12.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.